...of XVR011 to treat COVID-19. VIB, UCB Ventures, SFPI-FPIM, V-Bio Ventures, SRIW, Noshaq, Vives IUF, SambrInvest...

...backed by new investors Korean Investment Partners, Shinhan-Cognitive Start-up Fund, UTC 2019 Bioventurefund, SRIW and Sambrinvest...

...from institutional investors for the first time, CEO Dominique Demolle told BioCentury. Innovation Fund and Sambrinvest...

...million) on Sept. 26 in a series B round led by Fund+. SFPI, S.R.I.W. and Sambrinvest...

...exceeding its EUR 100 million ($108.9 million) target. Investors included SFPI-FPIM, SRIW, Meusinvest, Spinventure and Sambrinvest...

...Type: Venture financing Raised: EUR7.7 million ($8.7 million) Investors: Institute of Pathology and Genetics; Invest4OncoDNA; Sambrinvest...

...Investors: Boehringer Ingelheim Venture Fund; venture arm of Shire plc ; Mitsui Global Investment; ATMI; Sambrinvest...

...Fund; the venture arm of Shire plc (LSE:SHP; NASDAQ:SHPGY); Mitsui Global Investment; ATMI (NASDAQ:ATMI); and Sambrinvest...

...Fund; the venture arm of Shire plc (LSE:SHP; NASDAQ:SHPGY); Mitsui Global Investment; ATMI (NASDAQ:ATMI); and Sambrinvest...